Article Text
Abstract
Objectives To assess the potential role of clinical trial (CT) registries and other resources available to research ethics committees (RECs) in the evaluation of complex CT protocols in low-income and middle-income countries.
Methodology Using a case study approach, the authors examined the decision-making process of a REC in Argentina and its efforts to use available resources to decide on a complex protocol. We also analysed the information in the USA and other CT registries and consulted 24 CT experts in seven countries.
Findings Information requested by the Argentinean REC from other national RECs and ethics’ experts was not useful to verify the adequacy of the REC's decision whether or not to approve the CT. The responses from the national regulatory agency and the sponsor were not helpful either. The identification of international resources that could assist was beyond the REC's capability. The information in the USA and other CT registries is limited, and at times misleading; and its accuracy is not verified by register keepers.
Discussion and conclusion RECs have limited access to experts and institutions that could assist them in their deliberations. Sponsors do not always answer RECs’ request for information to properly conduct the ethical and methodological assessment of CT protocols. The usefulness of the CT registries is curtailed by the lack of appropriate codes and by data errors. Information about reasons for rejection, withdrawal or suspension of the trial should be included in the registries. Establishing formal channels of communication among national and foreign RECs and with independent international reference centres could strengthen the ethical review of CT protocols.
- Clinical trials
- Drugs and Drug Industry
- Ethics Committees/Consultation
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Research ethics committees in Europe: implementing the directive, respecting diversity
- Do we really know how many clinical trials are conducted ethically? Why research ethics committee review practices need to be strengthened and initial steps we could take to strengthen them
- Problems and development strategies for research ethics committees in China ’s higher education institutions
- Can an ethics officer role reduce delays in research ethics approval? A mixed - method evaluation of an improvement project
- Results of a self-assessment tool to assess the operational characteristics of research ethics committees in low - and middle - income countries
- Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation
- Research involving storage and use of human tissue: how did the Human Tissue Act 2004 affect decisions by research ethics committees
- Standards for research ethics committees: purpose, problems and the possibilities of other approaches
- Research ethics committee decision - making in relation to an efficient neonatal trial
- Lay REC members: patient or public